Compound ID | 2100
Class: Aminoglycoside
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive, Gram-negative & Antimycobacterial |
| Mechanism of action: | Protein synthesis inhibitor. Binds to the 30S ribosomal subunit |
| Target Pathogen: | Broad spectrum activity including Mycobacterium |
| Description: | Natural product from Streptomyces griseus |
| Year first mentioned: | 1944 |
| Highest development stage: | Approved by FDA in 1946 |
| Development status: | Approved |
| Reason dropped: | Other formulations were discontinued |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/19649 |
| Guide to Pharmacology: | streptomycin |
| Citations: |
|